Therese B. Deramaudt
University of Pennsylvania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Therese B. Deramaudt.
PLOS ONE | 2007
Marina Pasca di Magliano; Andrew V. Biankin; Patrick W. Heiser; David A. Cano; Pedro J. A. Gutiérrez; Therese B. Deramaudt; Davendra Segara; Amanda C. Dawson; James G. Kench; Susan M. Henshall; Robert L. Sutherland; Andrzej A. Dlugosz; Anil K. Rustgi; Matthias Hebrok
Pancreatic ductal adenocarcinoma (PDA) is an extremely aggressive malignancy, which carries a dismal prognosis. Activating mutations of the Kras gene are common to the vast majority of human PDA. In addition, recent studies have demonstrated that embryonic signaling pathway such as Hedgehog and Notch are inappropriately upregulated in this disease. The role of another embryonic signaling pathway, namely the canonical Wnt cascade, is still controversial. Here, we use gene array analysis as a platform to demonstrate general activation of the canonical arm of the Wnt pathway in human PDA. Furthermore, we provide evidence for Wnt activation in mouse models of pancreatic cancer. Our results also indicate that Wnt signaling might be activated downstream of Hedgehog signaling, which is an early event in PDA evolution. Wnt inhibition blocked proliferation and induced apoptosis of cultured adenocarcinoma cells, thereby providing evidence to support the development of novel therapeutical strategies for Wnt inhibition in pancreatic adenocarcinoma.
Oncogene | 2004
Munenori Takaoka; Hideki Harada; Therese B. Deramaudt; Kenji Oyama; Claudia D. Andl; Cameron N. Johnstone; Ben Rhoades; Gregory H. Enders; Oliver G. Opitz; Hiroshi Nakagawa
Oncogenic Ras induces premature senescence in primary cells. Such an oncogene-induced senescence involves activation of tumor suppressor genes that provide a checkpoint mechanism against malignant transformation. In mouse, the ARF–p53 pathway mediates Ha-RasG12V-induced senescence, and p19ARF−/− and p53−/− cells undergo transformation upon Ras activation. In addition, mouse cells, unlike human cells, express constitutively active telomerase and have long telomeres. However, it is unclear how Ras activation affects human cells of epithelial origin with p53 mutation and/or telomerase activation. In order to address this question, Ha-RasG12V was expressed ectopically in primary as well as hTERT-immortalized human esophageal keratinocytes stably expressing dominant-negative p53 mutants. In human esophageal keratinocytes, we found that Ha-RasG12V induced senescence regardless of p53 status and telomerase activation. Ras activation resulted in changes of cellular morphology, activation of senescence-associated β-galactosidase, and suppression of cell proliferation, all coupled with reduction in the hyperphosphorylated form of the retinoblastoma protein (pRb). Furthermore, Ha-RasG12V upregulated p16INK4a and downregulated cyclin-dependent kinase Cdk4 in human esophageal keratinocytes. Thus, Ras-mediated senescence may involve distinct mechanisms between human and mouse cells. Inactivation of the pRb pathway may be necessary for Ras to overcome senescence and transform human esophageal epithelial cells.
Molecular and Cellular Biology | 2006
Therese B. Deramaudt; Munenori Takaoka; Rabi Upadhyay; Mark Bowser; Jess Porter; Amy Lee; Ben Rhoades; Cameron N. Johnstone; Ralph Weissleder; Sunil R. Hingorani; Umar Mahmood; Anil K. Rustgi
ABSTRACT The genetic basis of pancreatic ductal adenocarcinoma, which constitutes the most common type of pancreatic malignancy, involves the sequential activation of oncogenes and inactivation of tumor suppressor genes. Among the pivotal genetic alterations are Ki-RAS oncogene activation and p53 tumor suppressor gene inactivation. We explain that the combination of these genetic events facilitates pancreatic carcinogenesis as revealed in novel three-dimensional cell (spheroid cyst) culture and in vivo subcutaneous and orthotopic xenotransplantation models. N-cadherin, a member of the classic cadherins important in the regulation of cell-cell adhesion, is induced in the presence of Ki-RAS mutation but subsequently downregulated with the acquisition of p53 mutation as revealed by gene microarrays and corroborated by reverse transcription-PCR and Western blotting. N-cadherin modulates the capacity of pancreatic ductal cells to migrate and invade, in part via complex formation with keratinocyte growth factor receptor and neural cell adhesion molecule and in part via interaction with p120-catenin. However, modulation of these complexes by Ki-RAS and p53 leads to enhanced cell migration and invasion. This preferentially induces the downstream effector AKT over mitogen-activated protein kinase to execute changes in cellular behavior. Thus, we are able to define molecules that in part are directly affected by Ki-RAS and p53 during pancreatic ductal carcinogenesis, and this provides a platform for potential new molecularly based therapeutic interventions.
Journal of Biological Chemistry | 2006
Therese B. Deramaudt; Mira M. Sachdeva; Melanie P. Wescott; Yuting Chen; Doris A. Stoffers; Anil K. Rustgi
Keratin 19 is a member of the cytokeratin family that is critical for maintenance of cellular architecture and organization, especially of epithelia. The pancreas has three distinct cell types, ductal, acinar, and islet, each with different functions. Embryologically, the pancreatic and duodenal homeobox 1 (PDX1) homeodomain protein is critical for the initiation of all pancreatic lineages; however, the later differentiation of the endocrine pancreas is uniquely dependent upon high PDX1 expression, whereas PDX1 is down-regulated in the ductal and acinar cell lineages. We find that this down-regulation may be required for normal ductal expression of cytokeratin K19. The K19 promoter-reporter gene assay demonstrates that ectopic PDX1 inhibits K19 reporter gene activity in primary pancreatic ductal cells. This is reinforced by our findings that retrovirally mediated stable transduction of PDX1 in primary pancreatic ductal cells suppresses K19 expression, and short interfering RNA to PDX1 in Min6 insulinoma cells results in the induction of normally undetectable K19. Complementary functional and biochemical approaches led to the unexpected finding that a multimeric complex of PDX1 and two members of the TALE homeodomain factor family, MEIS1a and PBX1b, regulates K19 gene transcription through a specific cis-regulatory element (–341 to –325) upstream of the K19 transcription start site. These data suggest a unifying mechanism whereby PDX1, myeloid ecotropic viral insertion site (MEIS), and pre-B-cell leukemia transcription factor 1 (PBX) may regulate ductal and acinar lineage specification during pancreatic development. Specifically, concomitant PDX1 suppression and MEIS isoform expression result in proper ductal and acinar lineage specification. Furthermore, PDX1 may inhibit the ductal differentiation program in the pancreatic endocrine compartment, particularly beta cells.
Journal of Oncology | 2010
Abdelkader Hamadi; Therese B. Deramaudt; Kenneth Takeda; Philippe Rondé
Cell adhesion and migration are key determinants in tumor metastasis. Adherence of tumor cell to the extracellular matrix is mediated via integrin containing focal adhesions (FAs). Binding of integrins to ECM triggers phosphorylation of two major components of FAs, focal adhesion kinase (FAK) and Src, activating downstream signaling pathway which leads to FA disassembly and cell migration. In this paper, we analyze how phosphorylation of FAK regulates its trafficking at FAs in living human astrocytoma cells. Upon pervanadate-induced FAK phosphorylation, phosphorylated FAK appeared highly expressed at newly formed membrane ruffles. This effect was abolished in presence of the specific Src inhibitor PP2. Our findings demonstrate that upon phosphorylation, FAK delocalizes from FAs to membrane ruffles.
Cancer Cell | 2005
Sunil R. Hingorani; Lifu Wang; Asha S. Multani; Chelsea Combs; Therese B. Deramaudt; Ralph H. Hruban; Anil K. Rustgi; Sandy Chang; David A. Tuveson
Cancer Research | 2003
Felix H. Brembeck; Franz S. Schreiber; Therese B. Deramaudt; Linden E. Craig; Ben Rhoades; Gary P. Swain; Paul J. Grippo; Doris A. Stoffers; Debra G. Silberg; Anil K. Rustgi
Biochimica et Biophysica Acta | 2005
Therese B. Deramaudt; Anil K. Rustgi
Gastroenterology | 2004
Franz S. Schreiber; Therese B. Deramaudt; Thomas Brunner; Michael I. Boretti; Keith J. Gooch; Doris A. Stoffers; Eric J. Bernhard; Anil K. Rustgi
Journal of Oncology | 2010
Claudia D. Andl; Ala-Eddin Al Moustafa; Therese B. Deramaudt; Geraldine M. O'Neill